Phosphatidyl ethanolamine with increased polyunsaturated fatty acids in compensation for plasmalogen defect in the Zellweger syndrome brain

Neuroscience Letters

Volumn 449, Issue 3, 2009, Pages 164-167

  Saitoh, Makiko ^a   Itoh, Masayuki ^b   Takashima, Sachio ^c   Mizuguchi, Masashi ^a   Iwamori, Masao ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KINKI UNIVERSITY   (Japan)

Author keywords

Peroxisome; Phosphatidyl ethanolamine; Plasmalogen; Polyunsaturated fatty acid; Zellweger syndrome

Indexed keywords

ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; PHOSPHATIDYLETHANOLAMINE; PLASMALOGEN; POLYUNSATURATED FATTY ACID;

ARTICLE; CEREBELLUM; CONTROLLED STUDY; GRAY MATTER; HUMAN; HUMAN TISSUE; MEMBRANE FLUIDITY; NERVE MEMBRANE; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; WHITE MATTER; ZELLWEGER SYNDROME;

BRAIN; CHROMATOGRAPHY, THIN LAYER; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; INFANT; MALE; PHOSPHATIDYLETHANOLAMINES; PLASMALOGENS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; ZELLWEGER SYNDROME;

EID: 57149119658     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.11.004     Document Type: Article

References (17)

1. Engelmann B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem. Soc. Trans. 32 (2004) 147-150
2. Farooqui A.A., Yang H.C., and Horrocks L.A. Plasmalogens, phospholipases A2 and signal transduction. Brain Res. - Brain Res. Rev. 21 (1995) 152-161
3. Gould S.J., Raymond G.V., and Valle D. The peroxisome biogenesis disorders. In: Scriver B.V., Beaudet S., Valle D., and Sly O. (Eds). The Metabolic and Molecular Basis of Inherited Disease (2001), McGraw-Hill, New York 3181-3217
4. Grønn M., Christensen E., Hagve T.A., and Bjørn O. The Zellweger syndrome: deficient conversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) and normal delta4-desaturase activity in cultured skin fibroblasts. Biochim. Biophys. Acta 1044 (1990) 249-254
5. Infante J.P., and Huszagh V.A. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. Mol. Cell. Biochem. 168 (1997) 101-115
6. Los D.A., and Murata N. Membrane fluidity and its roles in the perception of environmental signals. Biochim. Biophys. Acta 1666 (2004) 142-157
7. Martinez M. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation?. Neurology 40 (1990) 1292-1298
8. Martinez M. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res. 583 (1992) 171-182
9. Moser A.B., Kreiter N., Bezman L., Lu S., Raymond G.V., Naidu S., and Moser H.M. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45 (1999) 100-110
10. Nagan N., and Zoeller R.A. Plasmalogens: biosynthesis and functions. Prog. Lipid Res. 40 (2001) 199-229
11. Nagura M., Saito M., Iwamori M., Sakakihara Y., and Igarashi T. Alterations of FFA metabolism and membrane fluidity in peroxisome-defective mutant ZP102 cells. Lipids 39 (2004) 43-50
12. Powers J.M., Tummons R.C., Caviness Jr. V.S., Moser A.B., and Moser H.W. Structural and chemical alterations in the cerebral maldevelopment of fetal cerebro-hepato-renal (Zellweger) syndrome. J. Neuropath. Exp. Neurol. 48 (1989) 270-289
13. Saito M., Iwamori M., Lin B., Oka A., Fujiki Y., Shimozawa N., Kamoshita S., Yanagisawa M., and Sakakihara Y. Accumulation of glycolipids in mutant Chinese hamster ovary cells (Z65) with defective peroxisomal assembly and comparison of the metabolic rate of glycosphingolipids between Z65 cells and wild-type CHO-K1 cells. Biochim. Biophys. Acta 1438 (1999) 55-62
14. Saito M., Horikawa M., Iwamori Y., Sakakihara Y., Mizuguchi M., Igarashi T., Fujiki Y., and Iwamori M. Alterations in the molecular species of plasmalogen phospholipids and glycolipids due to peroxisomal dysfunction in Chinese hamster ovary-mutant Z65 cells by FABMS method. J. Chromatogr. B 852 (2007) 367-373
15. Saitoh M., Sakakihara Y., Mizuguchi M., Ito M., Takashima S., Iwamori M., Kamoshita S., and Igarashi T. Increase of ceramide monohexoside and dipalmitoyl glycerophospholipids in the brain of Zellweger syndrome. Neurosci. Lett. 417 (2007) 165-170
16. Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J. Lipid Res. 9 (1968) 570-579
17. Tatsumi K., Saito M., Lin B., Iwamori M., Ichiseki H., Shimozawa N., Kamoshita S., Igarashi T., and Sakakihara Y. Enhanced expression of a-series gangliosides in fibroblasts of patients with peroxisome biogenesis disorders. Biochim. Biophys. Acta 1535 (2001) 285-293